Skip to main content
. Author manuscript; available in PMC: 2023 Sep 27.
Published in final edited form as: Int J Toxicol. 2023 Apr 26;42(5):407–419. doi: 10.1177/10915818231170527

Figure 3.

Figure 3.

Effects of diet and trans-nonachlor exposure on hepatic steatosis. Liver triglyceride content (A) was measured as an index of hepatic steatosis and serum ALP (B) and serum ALT (C) were measured as indices of hepatic health/function following 16 weeks of LFD or HFD intake with 0, .5 or 5 ppm of trans-nonachlor. Data represents the mean ± SEM of 8–9 animals/group. #P ≤ .05 vs the corresponding dose of trans-nonachlor in LFD.